Advertisement

Salivary Hypofunction in Aging Adults

  • Catherine Hong
  • João N. A. R. FerreiraEmail author
Chapter

Abstract

  • Rapid progression to an edentulous status due to rampant tooth decay, opportunistic infections, inability to retain removable prostheses, discomfort during eating and speaking, burning sensation of the mouth, and diminished taste acuity are some of the reported signs and symptoms of dry mouth in aging adults.

  • A variety of symptomatic measures are available to alleviate dry mouth symptoms, but these largely fall under two categories: (1) saliva substitutes and lubricants and (2) saliva stimulants for local or systemic application.

References

  1. 1.
    Ship J, et al. How much saliva is enough? “Normal” function defined. J Am Dent Assoc. 1991;122:63–9.CrossRefPubMedGoogle Scholar
  2. 2.
    Thomson WM, et al. The xerostomia inventory: a multi-item approach to measuring dry mouth. Community Dent Health. 1999;16:12–7.PubMedGoogle Scholar
  3. 3.
    Ship JA. Xerostomia and the geriatric patient. Prog Geriatr. 2002;50:535–43.CrossRefGoogle Scholar
  4. 4.
    Dawes C. Physiological factors affecting salivary flow rate, oral sugar clearance and the sensation of dry mouth in man. J Dent Res. 1987;66:648–53.CrossRefPubMedGoogle Scholar
  5. 5.
    Liu B, et al. Xerostomia and salivary hypofunction in vulnerable elders: prevalence and etiology. Oral Surg Oral Med Oral Pathol Oral Radiol. 2012;114:52–60.CrossRefPubMedGoogle Scholar
  6. 6.
    Schein OD, et al. Dry eye and dry mouth in the elderly: a population-based assessment. Arch Intern Med. 1999;159:1359–63.CrossRefPubMedGoogle Scholar
  7. 7.
    Sreebny LM, et al. A reference guide to drugs and dry mouth – 2nd edition. Gerodontology. 1997;14:33–47.CrossRefPubMedGoogle Scholar
  8. 8.
    Orellana MF, et al. Prevalence of xerostomia in population based samples: a systematic review. J Public Health Dent. 2006;66:152–8.CrossRefPubMedGoogle Scholar
  9. 9.
    Matear DW, et al. Associations between xerostomia and health status indicators in the elderly. J R Soc Health. 2006;126:79–85.CrossRefGoogle Scholar
  10. 10.
    Navazesh M, et al. Relationship between salivary flow rates and Candida albicans counts. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1995;80:284–8.CrossRefPubMedGoogle Scholar
  11. 11.
    Navazesh M, et al. Clinical criteria for the diagnosis of salivary gland hypofunction. J Dent Res. 1992;71:1363–9.CrossRefPubMedGoogle Scholar
  12. 12.
    Thomson WM. Measuring change in dry-mouth symptoms over time using the xerostomia inventory. Gerodontology. 2007;24(1):30–5.CrossRefPubMedGoogle Scholar
  13. 13.
    Jones JM, et al. Comparison of three salivary flow rate assessment methods in an elderly population. Community Dent Oral Epidemiol. 2000;28:177–84.CrossRefPubMedGoogle Scholar
  14. 14.
    Heintze U, et al. Secretion rate and buffer effect of resting and stimulated whole saliva as a function of age and sex. Swed Dent J. 1983;7:227–38.PubMedGoogle Scholar
  15. 15.
    Pia A, et al. Imaging of the major salivary glands. Clin Physiol Funct Imaging. 2016;36:1–10.CrossRefGoogle Scholar
  16. 16.
    Teppo H, et al. A follow-up study of minimally invasive lip biopsy in the diagnosis of Sjögren’s syndrome. Clin Rheumatol. 2007;26:1099–103.CrossRefPubMedGoogle Scholar
  17. 17.
    Furness S et al. Interventions for management of dry mouth: topical therapies. Cochrane Database Syst Rev. 2011;(12):CD008934.Google Scholar
  18. 18.
    Ramos-Casals M, et al. Treatment of primary Sjögren’s syndrome: a systematic review. JAMA. 2000;304(4):452.CrossRefGoogle Scholar
  19. 19.
    Fife RS, Chase WF, Dore RK, Wiesenhutter CW, Lockhart PB, Tindall E, Suen JY. Cevimeline for the treatment of xerostomia in patients with Sjögren syndrome: a randomized trial. Arch Intern Med. 2002;162(11):1293.CrossRefPubMedGoogle Scholar
  20. 20.
    Papas AS, Sherrer YS, Charney M, Golden HE, Medsger Jr TA, Walsh BT, Trivedi M, Goldlust B, Gallagher SC. Successful treatment of dry mouth and dry eye symptoms in Sjögren’s syndrome patients with oral pilocarpine: a randomized, placebo-controlled. Dose-Adjust Study J Clin Rheumatol. 2004;10(4):169.CrossRefGoogle Scholar
  21. 21.
    Nutting CM, et al. Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): a phase 3 multicentre randomised controlled trial. Lancet Oncol. 12(2):127.Google Scholar
  22. 22.
    Banting DW, Papas A, Clark DC, Proskin HM, Schultz M, Perry R. The effectiveness of 10% chlorhexidine varnish treatment on dental caries incidence in adults with dry mouth. Gerodontology. 2000;17(2):67.CrossRefPubMedGoogle Scholar
  23. 23.
    Hay KD, Thomson WM. A clinical trial of the anti-caries efficacy of casein derivatives complexed with calcium phosphate in patients with salivary gland dysfunction. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2002;93(3):271.CrossRefPubMedGoogle Scholar
  24. 24.
    Jha N, et al. Phase III randomized study: oral pilocarpine versus submandibular salivary gland transfer protocol for the management of radiation induced xerostomia. Head Neck. 2009;31(2):234.CrossRefPubMedGoogle Scholar
  25. 25.
    Wasserman TH, Brizel DM, Henke M, Monnier A, Eschwege F, Sauer R, Strand V. Influence of intravenous amifostine on xerostomia, tumor control, and survival after radiotherapy for head-and- neck cancer: 2-year follow-up of a prospective, randomized, phase III trial. Int J Radiat Oncol Biol Phys. 2005;63(4):985.CrossRefPubMedGoogle Scholar
  26. 26.
    Strietzel FP, et al. Electrostimulating device in the management of xerostomia. Oral Dis. 2007;13(2):206–13.CrossRefPubMedGoogle Scholar
  27. 27.
    Fomer L, et al. Does hyperbaric oxygen treatment have potential to increase salivary flow rate and reduce xerostomia in previously irradiated head and neck cancer patients? A pilot study. Oral Oncol. 2011;47(6):546.CrossRefGoogle Scholar
  28. 28.
    Kruize AA, et al. Hydrochloroquine treatment of primary Sjögren’s syndrome: a two year double blind crossover trial. Ann Rheum Dis. 1993;52(5):360.Google Scholar
  29. 29.
    Mizrachi A, Cotrim AP, Katabi N, Mitchell JB, Verheij M, Haimovitz-Friedman A. Radiation-induced microvascular injury as a mechanism of salivary gland hypofunction and potential target for radioprotectors. Radiat Res. 2016;186(2):189–95.Google Scholar
  30. 30.
    Lombaert I, Movahednia MM, Adine C, Ferreira JN. Salivary gland regeneration: therapeutic approaches from stem cells to tissue organoids. Stem Cells. 2017;35(1):97–105.Google Scholar
  31. 31.
    Ferreira JN, Rungarunlert S, Urkasemsin G, Adine C, Souza GR. Three-dimensional bioprinting nanotechnologies towards clinical application of stem cells and their secretome in salivary gland regeneration. Stem Cells Int. 2016;2016:7564689. doi:  10.1155/2016/7564689. Epub 2016 Dec 20.

Copyright information

© Springer International Publishing AG 2017

Authors and Affiliations

  1. 1.Orthodontics and Paediatric Dentistry, Faculty of DentistryNational University of SingaporeSingaporeSingapore
  2. 2.Oral and Maxillofacial Surgery, Faculty of DentistryNational University of SingaporeSingaporeSingapore

Personalised recommendations